Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Roberts, Andrew W., Ma, Shuo, Kipps, Thomas J., Coutre, Steven E., Davids, Matthew S., Eichhorst, Barbara, Hallek, Michael, Byrd, John C., Humphrey, Kathryn, Zhou, Lang, Chyla, Brenda, Nielsen, Jacqueline, Potluri, Jalaja, Kim, Su Young, Verdugo, Maria, Stilgenbauer, Stephan, Wierda, William G., Seymour, John F.
Published in Blood (11.07.2019)
Published in Blood (11.07.2019)
Get full text
Journal Article
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
Flinn, Ian W., Hillmen, Peter, Montillo, Marco, Nagy, Zsolt, Illés, Árpád, Etienne, Gabriel, Delgado, Julio, Kuss, Bryone J., Tam, Constantine S., Gasztonyi, Zoltán, Offner, Fritz, Lunin, Scott, Bosch, Francesco, Davids, Matthew S., Lamanna, Nicole, Jaeger, Ulrich, Ghia, Paolo, Cymbalista, Florence, Portell, Craig A., Skarbnik, Alan P., Cashen, Amanda F., Weaver, David T., Kelly, Virginia M., Turnbull, Barry, Stilgenbauer, Stephan
Published in Blood (06.12.2018)
Published in Blood (06.12.2018)
Get full text
Journal Article
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Lampson, Benjamin L., Kasar, Siddha N., Matos, Tiago R., Morgan, Elizabeth A., Rassenti, Laura, Davids, Matthew S., Fisher, David C., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe, Abramson, Jeremy S., Arnason, Jon E., Kipps, Thomas J., Fein, Joshua, Fernandes, Stacey, Hanna, John, Ritz, Jerome, Kim, Haesook T., Brown, Jennifer R.
Published in Blood (14.07.2016)
Published in Blood (14.07.2016)
Get full text
Journal Article
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
Seymour, John F, Prof, Ma, Shuo, MD, Brander, Danielle M, MD, Choi, Michael Y, MD, Barrientos, Jacqueline, MD, Davids, Matthew S, MD, Anderson, Mary Ann, MBBS, Beaven, Anne W, MD, Rosen, Steven T, Prof, Tam, Constantine S, MD, Prine, Betty, BS, Agarwal, Suresh K, PhD, Munasinghe, Wijith, PhD, Zhu, Ming, PhD, Lash, L Leanne, PhD, Desai, Monali, MD, Cerri, Elisa, MD, Verdugo, Maria, MD, Kim, Su Young, MD, Humerickhouse, Rod A, MD, Gordon, Gary B, MD, Kipps, Thomas J, Prof, Roberts, Andrew W, Prof
Published in The lancet oncology (01.02.2017)
Published in The lancet oncology (01.02.2017)
Get full text
Journal Article
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
Anderson, Mary Ann, Deng, Jing, Seymour, John F., Tam, Constantine, Kim, Su Young, Fein, Joshua, Yu, Lijian, Brown, Jennifer R., Westerman, David, Si, Eric G., Majewski, Ian J., Segal, David, Heitner Enschede, Sari L., Huang, David C.S., Davids, Matthew S., Letai, Anthony, Roberts, Andrew W.
Published in Blood (23.06.2016)
Published in Blood (23.06.2016)
Get full text
Journal Article
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Montero, Joan, Stephansky, Jason, Cai, Tianyu, Griffin, Gabriel K, Cabal-Hierro, Lucia, Togami, Katsuhiro, Hogdal, Leah J, Galinsky, Ilene, Morgan, Elizabeth A, Aster, Jon C, Davids, Matthew S, LeBoeuf, Nicole R, Stone, Richard M, Konopleva, Marina, Pemmaraju, Naveen, Letai, Anthony, Lane, Andrew A
Published in Cancer discovery (01.02.2017)
Published in Cancer discovery (01.02.2017)
Get full text
Journal Article
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Davids, Matthew S., Kim, Haesook T., Costello, Caitlin, Herrera, Alex F., Locke, Frederick L., Maegawa, Rodrigo O., Savell, Alexandra, Mazzeo, Michael, Anderson, Adrienne, Boardman, Alexander P., Weber, Augustine, Avigan, David, Chen, Yi-Bin, Nikiforow, Sarah, Ho, Vincent T., Cutler, Corey, Alyea, Edwin P., Bachireddy, Pavan, Wu, Catherine J., Ritz, Jerome, Streicher, Howard, Ball, Edward D., Bashey, Asad, Soiffer, Robert J., Armand, Philippe
Published in Blood (11.06.2020)
Published in Blood (11.06.2020)
Get full text
Journal Article
The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival
Danilov, Alexey V, Flinn, Ian W, Davids, Matthew S, Gregory, Beth, Bentur, Ohad, Sidransky, David, Brown, Jennifer R
Published in Haematologica (Roma) (01.10.2024)
Published in Haematologica (Roma) (01.10.2024)
Get full text
Journal Article
Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability
Azevedo, Roberta S, Morelli, Francesca, Mashima, Kiyomi, Fardoun, Rayan, Tyekucheva, Svitlana, Fernandes, Stacey, Shupe, Samantha, Terra, Marissa, Patel, Anisha, Davids, Matthew S, Yu, Joseph, Brown, Jennifer R
Published in Haematologica (Roma) (21.11.2024)
Published in Haematologica (Roma) (21.11.2024)
Get full text
Journal Article
The redox-senescence axis and its therapeutic targeting
Ngoi, Natalie YL, Liew, Angeline QX, Chong, Stephen J.F., Davids, Matthew S., Clement, Marie-Veronique, Pervaiz, Shazib
Published in Redox biology (01.09.2021)
Published in Redox biology (01.09.2021)
Get full text
Journal Article
Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison
Al-Sawaf, Othman, Jen, Min-Hua, Hess, Lisa M, Zhang, Jiewen, Goebel, Benjamin, Pagel, John M, Abhyankar, Sarang, Davids, Matthew S, Eyre, Toby A
Published in Haematologica (Roma) (01.06.2024)
Published in Haematologica (Roma) (01.06.2024)
Get full text
Journal Article
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax
Zhu, Fen, Crombie, Jennifer L, Ni, Wei, Hoang, Nguyet-Minh, Garg, Swati, Hackett, Liam, Chong, Stephen J F, Collins, Mary C, Rui, Lixin, Griffin, James, Davids, Matthew S
Published in Haematologica (Roma) (01.01.2024)
Published in Haematologica (Roma) (01.01.2024)
Get full text
Journal Article
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
Sandova, Veronika, Pavlasova, Gabriela Mladonicka, Seda, Vaclav, Cerna, Katerina Amruz, Sharma, Sonali, Palusova, Veronika, Brychtova, Yvona, Pospisilova, Sarka, Fernandes, Stacey M, Panovska, Anna, Doubek, Michael, Davids, Matthew S, Brown, Jennifer R, Mayer, Jiri, Mraz, Marek
Published in Haematologica (Roma) (01.11.2021)
Published in Haematologica (Roma) (01.11.2021)
Get full text
Journal Article
Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies
Allan, John N, Pinilla-Ibarz, Javier, Gladstone, Douglas E, Patel, Krish, Sharman, Jeff P, Wierda, William G, Choi, Michael Y, O'Brien, Susan M, Shadman, Mazyar, Davids, Matthew S, Pagel, John M, Yimer, Habte A, Ward, Renee, Acton, Gary, Taverna, Pietro, Combs, Daniel L, Fox, Judith A, Furman, Richard R, Brown, Jennifer R
Published in Haematologica (Roma) (01.04.2022)
Published in Haematologica (Roma) (01.04.2022)
Get full text
Journal Article
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Ujjani, Chaitra S., Jung, Sin-Ho, Pitcher, Brandelyn, Martin, Peter, Park, Steven I., Blum, Kristie A., Smith, Sonali M., Czuczman, Myron, Davids, Matthew S., Levine, Ellis, Lewis, Lionel D., Smith, Scott E., Bartlett, Nancy L., Leonard, John P., Cheson, Bruce D.
Published in Blood (24.11.2016)
Published in Blood (24.11.2016)
Get full text
Journal Article
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy
Mato, Anthony R, Wierda, William G, Davids, Matthew S, Cheson, Bruce D, Coutre, Steven E, Choi, Michael, Furman, Richard R, Heffner, Leonard, Barr, Paul M, Eradat, Herbert, Ford, Sharanya M, Zhou, Lang, Verdugo, Maria, Humerickhouse, Rod A, Potluri, Jalaja, Byrd, John C
Published in Haematologica (Roma) (01.11.2019)
Published in Haematologica (Roma) (01.11.2019)
Get full text
Journal Article